Collection: Otitis Media with Effusion (OME)

Otitis Media with effusion (OME ) represents one of the most common diseases of childhood and consists of the accumulation of a mucous effusion in the middle ear and the Eustachian tube, a canal that connects the middle ear to the nasopharynx i.e. the throat. It is also known as tubal catarrh, catarrhal otitis, tubotimpanitis and secretory otitis.

The presence of the mucous effusion in the middle ear prevents ventilation of the middle ear (air passage) and, at the same time, can alter auditory functions, lead to pathological changes in the tympanic membrane and case as well as the ossicular chain (ossicles).

OME is a condition that typically occurs in children: the first onset may occur as early as the first months of life, usually after the fourth month. Nevertheless, it can be detected as early as the second month of life.

It is often asymptomatic and hard to detect without regular ENT checkups. It’s important to consult a specialist, especially in cases of recurring acute otitis, ear pain, reduced hearing, or attention and speech issues.

Ciliacell is the only product specifically designed to effectively treat Otitis Media with Effusion characterized by the above clinical manifestations, namely:
Edema of the naso-sinus mucosa, slowing or stopping of ciliary mobility and motility, accumulation of secretions in the Eustachian Tubes.

Ciliacell is a patent-protected product of Nevia Biotech and has been tested in several internationally prominent clinical trials.

The demonstrated clinical healing efficacy is more than 90%.